Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Research & Development (2016 - 2025)

Bio-Techne (TECH) has 17 years of Research & Development data on record, last reported at $23.1 million in Q4 2025.

  • For Q4 2025, Research & Development fell 7.56% year-over-year to $23.1 million; the TTM value through Dec 2025 reached $98.0 million, down 0.67%, while the annual FY2025 figure was $99.5 million, 2.93% up from the prior year.
  • Research & Development reached $23.1 million in Q4 2025 per TECH's latest filing, down from $24.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $26.0 million in Q2 2025 and bottomed at $17.1 million in Q1 2021.
  • Average Research & Development over 5 years is $23.0 million, with a median of $23.3 million recorded in 2022.
  • Peak YoY movement for Research & Development: soared 34.65% in 2021, then decreased 7.56% in 2025.
  • A 5-year view of Research & Development shows it stood at $20.6 million in 2021, then rose by 8.76% to $22.5 million in 2022, then grew by 2.03% to $22.9 million in 2023, then grew by 9.16% to $25.0 million in 2024, then fell by 7.56% to $23.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $23.1 million in Q4 2025, $24.2 million in Q3 2025, and $26.0 million in Q2 2025.